TOR1B and breast cancer: The AUC of TOR1B showed significant predictive capability for BM in BC patients in both the E-MTAB-365 and GSE2034 datasets (AUC = 0.627, p < 0.001 and AUC = 0.663, p < 0.001, respectively) (Fig. 3).